Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic Anticipating First Care Link FDA Approval in November

This article was originally published in The Gray Sheet

Executive Summary

Medtronic Cardiac Rhythm Management expects its Internet-based Care Link Network patient management system to generate $250 mil. in five years.

You may also be interested in...



Medtronic CareLink Cardiac Remote Management Tools Get FDA Go-Ahead

Medtronic plans to file additional PMA supplements to incorporate its CareLink remote patient management network with a range of implantable cardiac devices

Medtronic CareLink Cardiac Remote Management Tools Get FDA Go-Ahead

Medtronic plans to file additional PMA supplements to incorporate its CareLink remote patient management network with a range of implantable cardiac devices

Biotronik Will Launch Telemetry Pacemaker Following Marketing Trial

Biotronik will conduct a 90-day marketing trial of its BAO3 pacemaker and Home Monitoring System before fully launching the products in the U.S. market.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel